Biocardia Stock Forward View - Relative Strength Index
| BCDA Stock | USD 1.27 -0.02 -1.55% |
Predicting Biocardia's future price is a multi-variable problem that combines fundamental signals, technical structure, and market sentiment. This module focuses specifically on the hype and news dimension of that forecast.
At present, RSI for Biocardia stands at 49, indicating moderately negative momentum. For Biocardia, this sub-50 reading points to a soft downward drift rather than an aggressive selloff.Momentum
Impartial
Oversold | Overbought |
This section relates Biocardia headline activity to recent price behavior and peer context.
Biocardia after-hype prediction price | $ 1.27 |
Hype signals are presented as complementary context to forecasting, technicals, analyst estimates, earnings, and momentum.
Biocardia | Build AI portfolio with Biocardia Stock |
Biocardia Additional Predictive Modules
Most predictive techniques to examine Biocardia price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Biocardia using various technical indicators. When you analyze Biocardia charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Check Biocardia Volatility | Backtest Biocardia | Information Ratio |
Biocardia Trading Date Momentum
| On March 12 2026 Biocardia was traded for 1.27 at the closing time. The top price for the day was 1.30 and the lowest listed price was 1.27 . The trading volume for the day was 17.6 K. The trading history from March 12, 2026 did not affect price variability. The overall trading delta against the current closing price is 0.00% . |
| Compare Biocardia to competition |
Other Forecasting Options for Biocardia
Whether a novice or experienced investor, anyone considering Biocardia needs to understand the dynamics of Biocardia's price movement. Price charts for Biocardia Stock contain a significant amount of noise that can distort investment decisions.Biocardia Related Equities
The following equities are related to Biocardia within the Health Care space and can be used for peer comparison, relative valuation, or portfolio diversification. Comparing Biocardia against peers on metrics such as P/E, margins, and return on equity helps contextualize its positioning and identify relative strengths or weaknesses.
| Risk & Return | Correlation |
Biocardia Market Strength Events
Analyzing market strength indicators for Biocardia enables investors to understand how the stock performs relative to overall market momentum. These indicators are valuable tools for identifying when to enter or exit positions in Biocardia.
Biocardia Risk Indicators
Identifying and analyzing Biocardia's key risk indicators is a foundational step in projecting how its price may evolve. This process helps investors quantify the risk associated with Biocardia's and decide how to manage it.
| Mean Deviation | 2.67 | |||
| Standard Deviation | 3.83 | |||
| Variance | 14.71 |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Story Coverage note for Biocardia
Coverage intensity for Biocardia matters because narrative visibility can influence sentiment, participation, and volatility around the name. The stronger process compares story flow with performance, theme classification, and the level of short-term market interest.
Contributor Headline
Latest Perspective From Macroaxis
Biocardia Short Properties
Short sentiment tied to Biocardia matters because heavier bearish pressure can change how quickly future price expectations become unstable. Used correctly, these measures can help investors decide when hedging or timing discipline may matter more than conviction alone.
| Common Stock Shares Outstanding | 2.7 M | |
| Cash And Short Term Investments | 2.4 M |
More Resources for Biocardia Stock Analysis
A structured review of Biocardia often starts with core financial statements and trend context. Financial ratios provide context for profitability, efficiency, and growth trends. Below are reports that help frame Biocardia Stock in context:Use Historical Fundamental Analysis of Biocardia to cross-verify projections for Biocardia. The historical view provides additional context.For more information on how to buy Biocardia Stock please use our How to Buy Biocardia Stock guide.Analysis related to Biocardia should be read together with other portfolio and risk tools before capital is reallocated. That is especially important when the goal is to improve the overall mix of instruments already held. You can also try the Bollinger Bands module to use Bollinger Bands indicator to analyze target price for a given investing horizon.
The market value of Biocardia is measured differently than book value, which reflects Biocardia accounting equity. Biocardia's market capitalization is 13.48 M. With a P/B ratio of 5.13, the market values Biocardia well above its book equity. Enterprise value stands at 8.83 M. The intrinsic value concept focuses on underlying worth, which can diverge from market price and book value. Valuation work aligns these measures into a single context.
Note that Biocardia's intrinsic value and market price are different measures derived from different inputs. For Biocardia, key inputs include a P/B ratio of 5.13, ROE of -3.17%, and revenue of 58 K. Trading price represents the transaction level agreed by market participants.